10/19/2005 5:13:13 PM
April 19, 2005 Reporting its Q1 financial results, the embattled pharmaceutical giant Pfizer came in about as expected. Before one-time charges, the company earned $4 billion (54 cents per share) on $13 billion of revenues, which was a 5% increase over the year earlier. The consensus forecasts called for 53 cents per share on $12.5 billion of total income.
Unfortunately, there were loads of special charges that brought net income lower. Subtract the special charges out, and the net GAAP profit is $301 million or 4 cents per share. Underneath the headline numbers, there was a lot of movement in sales. We take a look...
comments powered by